article
20 January 2023 | By Dr Chris Arendt (Takeda), Dr Daniel Teper (Cytovia Therapeutics)
In this article, Dr Daniel Teper and Dr Chris Arendt explore cellular therapies for cancer that provide an alternative to chimeric antigen receptor (CAR) T-cell therapy. In these Q&As, they outline their important work in immuno-oncology.